www.verygoodnewsisrael.blogspot.com
http://blogs.jpost.com/users/just-look-us-now
ISRAEL’S MEDICAL ACHIEVEMENTS
Surviving heart failure. Cardiologist Prof. Ilan Goldenberg from Israel’s Sheba Medical Center led an international study into cardiac insufficiency – also known as heart failure. It reported that an automatic cardiac pacemaker/defibrillator implanted at an early stage of common heart failure could extend life significantly.
http://www.jpost.com/Health-and-Science/Sheba-Medical-Center-team-heads-important-heart-failure-research-346957
Calcium absorption trial successful. Israel’s Amorphical has successfully completed a clinical trial of its amorphous calcium. The trial found that the patients’ absorption of amorphous calcium was double the average absorption of crystalline calcium. Amorphical aims to develop a product as a nutritional supplement.
http://www.globes.co.il/en/article-amorphical-calcium-absorption-trial-successful-1000925022
Sleep Apnea treatment for US citizens. Israel’s Itamar Medical has signed an exclusive marketing agreement with Medtronic Corporation to market the company’s sleep apnea diagnostic product to a select segment of the US market – patients with atrial fibrillation..
http://www.globes.co.il/en/article-itamar-signs-medtronic-distribution-deal-for-sleep-device–1000925010
Innovative endoscope gets USA approval. The US FDA has just approved the MUSE system from Israel’s Medigus. MUSE is a unique medical device that allows doctors to examine the stomach and esophagus with a tiny camera. The same device can then be used to stop acid reflux.
http://www.globes.co.il/en/article-medigus-gets-fda-nod-for-upgraded-muse-system-1000926318
How bacteria is controlled in the gut. Scientists from Israel’s Weizmann Institute have revealed the sophisticated mechanism that the digestive system uses to balance good and bad bacteria. A protein cluster called inflammasome monitors the bacterial population and signals the secretion of antibiotic proteins.
http://wis-wander.weizmann.ac.il/goblet-cells-get-their-germs#.Uy8V286oVey
US patent for Israeli stem cell technology. Israeli biotech Brainstorm has received a US patent for its autologous stem cell technology for the treatment of neuro-degenerative diseases. Brainstorm is preparing for its US upcoming multi-center Phase II trial with its proprietary NurOwn stem cell therapy.
http://www.brainstorm-cell.com/index.php/news-a-events/291-march-24-2014